LEASE BETWEEN DISCOVERY BUSINESS CENTER LLC AND TARSUS PHARMACEUTICALS, INC.Lease • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledSeptember 14th, 2020 Company Industry JurisdictionTHIS LEASE is made as of May 28, 2020, by and between DISCOVERY BUSINESS CENTER LLC, a Delaware limited liability company, hereafter called “Landlord,” and TARSUS PHARMACEUTICALS, INC., a Delaware corporation, hereafter called “Tenant.”
LICENSE AGREEMENTLicense Agreement • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 14th, 2020 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”), dated as of September 3, 2020 (the “Effective Date”), is made and entered into by and between Elanco Tiergesundheit AG, a Swiss corporation having place of business at Mattenstrasse 24A, 4058 Basel, Switzerland (“Elanco”) and Tarsus Pharmaceuticals, Inc., a Delaware corporation having its principal offices at 4590 MacArthur Blvd. Suite 500, Newport Beach, CA 92660 (“Tarsus”). Each of Elanco and Tarsus may be referred to herein as a “Party” and collectively as the “Parties.”
SUBLEASE AGREEMENTSublease Agreement • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 14th, 2020 Company IndustryTHIS SUBLEASE AGREEMENT (“Sublease”) is made and entered into this 29th day of May, 2020 by and between AVENT, INC., a Delaware corporation (hereinafter “Sublessor”) and TARSUS PHARMACEUTICALS, INC., a Delaware corporation (hereinafter “Sublessee”).
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 14th, 2020 Company IndustryThis Amendment to License Agreement (“Amendment”) is made and entered into as of September 3, 2020 (the “Amendment Effective Date”) by and between Elanco Tiergesundheit AG, a Swiss corporation having place of business at Mattenstrasse 24A, 4058 Basel, Switzerland (“Elanco”) and Tarsus Pharmaceuticals, Inc., a Delaware corporation having its principal offices at 4590 MacArthur Blvd. Suite 500, Newport Beach, CA 92660 (“Tarsus”).